Journal of Open Source Science
Menu

fork:pmid:28529692:abnormal-expression-of-atp1a1-and-atp1a2-in-breast-cancer-30ee8f18 Public

https://scm.piranha.sh/git/ada56728063306072cb24f17/sci-fork-pmid-28529692-abnormal-expression-of-atp1a1-and-atp1a2-in-breast-cancer-30ee8f18 · at 84eb13df156b

Abnormal expression of ATP1A1 and ATP1A2 in breast cancer

fork:pmid:28529692:abnormal-expression-of-atp1a1-and-atp1a2-in-breast-cancer-30ee8f18 · revision 8 · F1000Research

Original
2017
Created
2026-11-03
Ingested
2026-11-07
Paper record The research question, publication details and source material recorded for this paper.

Breast cancer is the first in incidence and the second in death among all solid tumors occurring in women. The identification of molecular genetic abnormalities in breast cancer is important to improve the results of treatment. In the present study, we analyzed microarray data of breast cancer expression profiling (NCBI GEO database, accession GSE65194), focusing on Na +/K +-ATPase coding genes. We found overexpression of the ATP1A1 and down-regulation of the ATP1A2. We expect that our research could help to improve the understanding of predictive and prognostic features of breast cancer. Keywords: breast cancer, Na+/K+-ATPase, gene expression, abnormality, ATP1A1, ATP1A2

Alexey Bogdanov, Fedor Moiseenko, Michael Dubina

DOI
10.12688/f1000research.10481.1
PMID
28529692
Journal
F1000Research
Published
2017
Revision
8
Format version
1.5
Content hash
sha256:26c4153596d79a37288fac302e042eedf392341ff41d031a6c3fdb56881fa565

Recomputed from the file: it matches.

Opened from
fork:pmid:28529692:abnormal-expression-of-atp1a1-and-atp1a2-in-breast-cancer-30ee8f18
Fork of pmid:28529692
Written
2026-11-03T10:54:57.000000Z
Updated
2026-11-03T15:45:20.889630Z
Made by
Automated Assays Administrator, Automated Assays
Source run
assays-session-30ee8f18-43ad-40ff-864f-b10e1b899c27
Data sources The sources the file names, with the access and the state the file records for each one.

manuscript · open · resolved

10.12688/f1000research.10481.1

https://doi.org/10.12688/f1000research.10481.1

xml · 8,810 bytes · sha256:b52c152ee6cd127bf20948915bce7ef4e8d743048657f0fe8c3441f877d98c57

Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.

table · open · verified

section[1]/table-wrap[1]#T1

jats-table · 598 bytes · sha256:093de1b1ff705f0e3a405721e80dff9250fdee11708bf051db5b2299349651b4

NKA genes expression in breast cancer samples relative to normal breast tissue.

The samples analysed The group sizes the file holds, and the group sizes the paper itself states. A run is only comparable when it used the same cohort.

In this file

CellLine
14
Healthy
11
Her2
39
Luminal A
29
Luminal B
30
TNBC
55

As the paper states them

Her2
30
Lum A
29
Lum B
30
TNBC
41
normal breast tissue
11

141 samples in total.

Reference group: normal breast tissue.

Array data for 41 triple negative samples (TNBC group), 30 Her2-positive (Her2 group), 30 Luminal B (Lum B group), 29 Luminal A (Lum A group) breast cancer samples and 11 normal breast tissue samples were investigated.

Reproducibility map Follow the research stages and see which inputs each stage needs and what state the file records for it.

In GSE65194 Affymetrix microarray data analyzed by one-way between-subjects ANOVA, ATP1A1 was overexpressed approximately 1.5-fold in all breast cancer groups (p<0.05), while ATP1A2 expression decreased by more than 2-fold (p<0.05).

  1. 1

    Validate the dataset schema and hash it

    complete

    computational

  2. 2

    Confirm at least two groups with at least two observations each

    complete

    computational

  3. 3

    Compute per-group descriptives

    complete

    computational

  4. 4

    Test variance homogeneity and screen each group for normality

    complete

    computational

  5. 5

    Run the one-way analysis of variance

    complete

    computational

  6. 6

    Compare every pair of groups and correct across the pairs

    complete

    computational

  7. 7

    Package the result and its hashes

    complete

    computational

The methods the paper publishes Each method as the paper states it, with the evidence the file holds for it.

Group comparison analysis

expressible

group_comparison_anova

alpha
{"type":"number","description":"The significance level, declared before the run and recorded with the result.","default":0.05}
Compare a continuous measurement across two or more groups with a one-way analysis of variance, report the assumption checks the test depends on, and compare every pair of groups with Welch's unequal-variance t statistic under Holm's correction.
The assays in this file Each assay the file names, with the operations it needs and the definition it was read from.

group-comparison-analysis

supported

assay:1 · primary · version 0.1.0

needs: group_comparison_rank_sum, group_comparison_wilcoxon, group_comparison_mann_whitney, student_t, welch_t, group_comparison_anova

sha256:f1c5d3dfb8ca3c3061030d0f366addd1f61dd994520aa65a406632940618b75a

Can this run here What the file says about running this experiment, and what still stands in the way.
State
blocked · tier R4
Blocked on
method:microarray_rma_normalise

can run: group_comparison_anova

Still to build

  • microarray_rma_normalise
  • group_relative_expression

method

The DSL catalogue has no operation for: microarray_rma_normalise, group_relative_expression.

capability

The corpus capability table owns computational analysis.

data

The GEO series resolves and its sample accessions are listed. No dataset was downloaded and no licence was read.

The result run What has run against this file, and the review the file carries.

Runs

2d090760-f2ae-423e-849f-dc58da829431

group_comparison_anova · complete

ran against
fork:pmid:28529692:abnormal-expression-of-atp1a1-and-atp1a2-in-breast-cancer-30ee8f18
version
0.1.0
provider
automated-assays-computational
result
9dd46f386a0e57d0d15cb2c6ecea5f48be988ebee6bdb03185e9373809493ac6
evidence
87ff3155b911ad594efd4d06168102fdee0c005e2f51b9edc0aae846081b9709

ccdb9e35-1e46-47c8-9fde-b096e3b2dca6

group_comparison_anova · complete

ran against
fork:pmid:28529692:abnormal-expression-of-atp1a1-and-atp1a2-in-breast-cancer-30ee8f18
version
0.1.0
provider
automated-assays-computational
result
9dd46f386a0e57d0d15cb2c6ecea5f48be988ebee6bdb03185e9373809493ac6
evidence
7d6e68368f4e57c5bf3fc7c047891d14bed7a479b42bcbc59828dea0b10faf95

30eab1f1-9658-4752-b04a-b6aa17a14a3a

group_comparison_anova · complete

ran against
fork:pmid:28529692:abnormal-expression-of-atp1a1-and-atp1a2-in-breast-cancer-30ee8f18
version
0.1.0
provider
automated-assays-computational
result
9dd46f386a0e57d0d15cb2c6ecea5f48be988ebee6bdb03185e9373809493ac6
evidence
9009b2063e89db5f8eb54e0d978d07e199de641c17497f35e6696b3878fded3e

b1a80714-f07f-4e92-8712-5875211bd4a5

group_comparison_anova · complete

ran against
fork:pmid:28529692:abnormal-expression-of-atp1a1-and-atp1a2-in-breast-cancer-30ee8f18
version
0.1.0
provider
automated-assays-computational
result
d2e043b2c582c00897bbf0561ebfbe31771e5768aebf6717eb8e7dc5c0e258e0
evidence
8f5d82deb63559b72eede3efa16f7ee2c8a0513caf5b1624801931b243d98a4e

b3d84aac-f651-4db8-b6d7-952c1067bc68

group_comparison_anova · complete

ran against
pmid:28529692
version
0.1.0
provider
automated-assays-computational
result
9dd46f386a0e57d0d15cb2c6ecea5f48be988ebee6bdb03185e9373809493ac6
evidence
39a33cc135b9e908a814f0854ae4337d69a77e91b6b4b08118eb1cfad1f00226

35855d74-da28-419b-9aff-6a2faab1cbb3

group_comparison_anova · complete

ran against
pmid:28529692
version
0.1.0
provider
automated-assays-computational
result
9dd46f386a0e57d0d15cb2c6ecea5f48be988ebee6bdb03185e9373809493ac6
evidence
54d4257e859ea5a046fd1aeeda50771d69be127be8ce5af864e03b330244e861

55e62ab5-1896-49a6-8660-084755f20b6b

group_comparison_anova · complete

ran against
pmid:28529692
version
0.1.0
provider
automated-assays-computational
result
54a410ca80264c03e91ef940661500f76af0af12ce97cf3f6005c0e6005d3608
evidence
ae2c9c04e9c7fa7fe01d8d2bca37c7d04d98d3e6adce5552011b255e09f4dffa

dad39f8c-48e8-4efd-b166-d521049482f4

group_comparison_anova · failed

ran against
pmid:28529692
version
0.1.0
provider
automated-assays-computational

17fdc411-b820-446f-ad1c-2707e0c7c7ce

group_comparison_anova · complete

ran against
pmid:28529692
version
0.1.0
provider
automated-assays-computational
result
d2e043b2c582c00897bbf0561ebfbe31771e5768aebf6717eb8e7dc5c0e258e0
evidence
5cb7247f5e740f9c91e38661e930c9d423780dac50bcca5d1d8bc03344f8e131

ddf18337-22c9-41f3-b428-91903ba5cb5e

group_comparison_anova · complete

ran against
pmid:28529692
version
0.1.0
provider
automated-assays-computational
result
d2e043b2c582c00897bbf0561ebfbe31771e5768aebf6717eb8e7dc5c0e258e0
evidence
a75426d81c2d534d0a5bf54f37a781bec8b8284e29638684c51eb2ea618e8135

9d2dcc1b-00f2-479b-9e50-1f99a52a1649

group_comparison_anova · complete

ran against
pmid:28529692
version
0.1.0
provider
automated-assays-computational
result
d2e043b2c582c00897bbf0561ebfbe31771e5768aebf6717eb8e7dc5c0e258e0
evidence
e5d965c9dcfd87e1f460d9f3b43d9e083c72ce77f348babd44d81c5ebda1c83e

7ee6eac8-e2d2-4cf7-832b-5a26f5c1626f

group_comparison_anova · complete

ran against
pmid:28529692
version
0.1.0
provider
automated-assays-computational
result
234ce160fd565c75d79da6bf3ff7703e74c34fce7f29f6b13fcb8b89adebf766
evidence
ce4c4c84ffa6fedfde751d02c3661158467b917cd83e93a36b6902816971e97b

818d9213-ad32-4a5e-8325-2d7c59a7743c

group_comparison_anova · complete

ran against
pmid:28529692
version
0.1.0
provider
automated-assays-computational
result
e109c9ff1d16759ac889e64591e5b8c2bbc149ce55335d783758c9e2c4805105
evidence
e6477384c3bbc834c3a15bd9b952f3a75c23a54e09340b4c3fe721081b2ec4e6

40b97cc2-c3b4-429f-b4ec-6ad4ef7d5085

group_comparison_anova · complete

ran against
pmid:28529692
version
0.1.0
provider
automated-assays-computational
result
e109c9ff1d16759ac889e64591e5b8c2bbc149ce55335d783758c9e2c4805105
evidence
37d41c54a1cf0055162706aa6b42103569b6471c1a9e91310d48d09c2158fe5b

Review carried by the file

absent

No person has reviewed this file. The reader's assessment is an opinion and not a decision.

Scope and limitations What this file does not cover, as the file itself states it.
  • execution.unbound: 2 runs against this record are not bound to a version of it, so are not published as evidence on an assay entry.

data

  • asset:data:geo:GSE65194 licence not read
  • asset:data:geo:GSE65194 not downloaded
  • data.group_sizes_conflict
  • data.sample_set_unresolved

readiness

  • method:microarray_rma_normalise

review

  • review.absent: this document is a working version. Review and publication are separate actions, and they belong to the Journal.
Forks opened from this paper Each fork is a repository of its own, with the paper it was opened from.

No fork has been opened from this paper yet.

Files

fork:pmid:28529692:abnormal-expression-of-atp1a1-and-atp1a2-in-breast-cancer-30ee8f18.json 286,923 bytes